TPG Growth Invests $75 Million in Precision for Medicine
Ropes & Gray advised TPG Growth, the middle market and growth equity investment platform of TPG, on its $75 million investment in Precision for Medicine, Inc.
Based in Bethesda, Md., and formed in 2012, Precision for Medicine is a specialty services company that supports pharmaceutical and life sciences companies through development and commercialization. The company helps its clients develop products, demonstrate economic value, validate outcomes and build differentiation within the health care marketplace.
With over $7 billion under management, TPG Growth targets investments in a broad range of industries and geographies. Its current and past investments cover a mix of iconic and innovative companies across technology, retail and entertainment.
Terms of the deal, announced Dec. 22, were not disclosed.
The New York-based Ropes & Gray team was led by private equity partner Carl Marcellino, and included corporate associates Hannah Jenkins and David Sandyk.